There is a segment of our culture that thinks "edgy" darkness, demonic imagery, and the occult are the height of rebellion. They think they’re tapping into some deep, ancient power that makes them part of a "chosen" underground. But if you actually look at the history of these forces, you’ll find the most embarrassing truth of all: Evil is the most unoriginal thing on Earth. 1. The Total Lack of Innovation Think about human history. We’ve gone from living in caves to building

This is the full story of what happened to Liam Ashley, pulling together the background, the strange interactions during the ride, and the details of the attack. The Setup: A Choice Made in Desperation In August 2006, Ian and Lorraine Ashley felt they were out of options with their 17-year-old son, Liam. He had been getting into trouble—minor thefts and joyriding—and they were worried his behavior was spiraling. They decided to press charges after he took his mother’s car, ho

Experts are warning that the rollback of specific climate and health protections will likely have the most severe impact on poor and minority communities. A new analysis focuses on areas like Louisiana’s "Cancer Alley," where industrial pollution is already linked to high rates of premature death. The report suggests that reducing federal oversight will lead to increased air and water contamination in these vulnerable zones. Environmental advocates argue that these communitie

The U.S. Navy has officially cleared Raytheon’s StormBreaker smart weapon for operational use on F/A-18-E/F Super Hornet strike fighters. This advanced weapon is designed to hit moving and stationary targets even in poor weather conditions. Its compact size allows aircraft to carry more munitions, increasing the number of targets a single flight can engage. Military officials stated that the integration of this technology significantly increases the lethality and survivabilit

The U.S. Food and Drug Administration has granted approval for a new combination therapy intended for adults with previously untreated chronic lymphocytic leukemia (CLL). This milestone establishes the first and only all-oral, fixed-duration regimen for these patients, allowing them to manage their condition without the need for traditional intravenous treatments. Medical experts are calling the approval a significant win for patient flexibility. Because the treatment is a "f